Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk

AIDS

Volumn 27, Issue 1, 2013, Pages 105-113

  Butler, Ailsa R ^a   Smith, Jennifer A ^a   Polis, Chelsea B ^b   Gregson, Simon ^a   Stanton, David ^b   Hallett, Timothy B ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

Author keywords

heterosexual transmission; HIV acquisition risk; injectable hormonal contraception; live births; maternal mortality; women

Indexed keywords

CONTRACEPTIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICA; ARTICLE; DEATH; FEMALE; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AFRICA, EASTERN; AFRICA, SOUTHERN; CONDOMS; CONTRACEPTIVE AGENTS; FAMILY PLANNING SERVICES; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INJECTIONS; MIDDLE AGED; MODELS, STATISTICAL; PREGNANCY; PREVALENCE; RISK FACTORS; SOUTH AMERICA;

EID: 84871624021     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835a5a52     Document Type: Article

References (38)

1. Darroch J, Sedgh G, Ball H. Contraceptive technologies: responding to women's needs. New York: Guttmacher Institute; 2011.
2. United Nations Department of Economic and Social Affairs, Population Division. World Contraceptive Use 2010 (POP/DB/CP/Rev2010). 2011.
3. Baeten JM, Benki S, Chohan V, Lavreys L, McClelland RS, Mandaliya K, et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007; 21:1771-1777. (Pubitemid 47237565)
4. Morrison CS, Chen P-L, Kwok C, Richardson BA, Chipato T, Mugerwa R, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010; 24:1778-1781.
5. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012; 12:19-26.
6. Wand H, Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS 2012; 26:375-380.
7. Morrison CS, Skoler-Karpoff S, Kwok C, Chen P-L, van de Wijgert J, Gehret-Plagianos M, et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS 2012; 26:497-504.
8. Reid S, Dai J, Wang, Sichalwe B, Akpomiemie G, Cowan F, et al. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr 2010; 53:606-613.
9. Kleinschmidt I, Rees H, Delany S, Smith D, Dinat N, Nkala B, et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 2007; 75:461-467. (Pubitemid 46764303)
10. Myer L, Denny L, Wright TC, Kuhn L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007; 36:166-174. (Pubitemid 47061592)
11. Kiddugavu M, Makumbi F, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. Int J Epidemiol 2003; 17:233-240. (Pubitemid 36183050)
12. Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. The Lancet 2005; 366:1182-1188. (Pubitemid 41393596)
13. Morrison CS, Wang J, Van Der Pol B, Padian N, Salata RA, Richardson BA. Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe. AIDS 2007; 21:1027-1034. (Pubitemid 46684334)
14. Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, et al. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS 2011; 25:1887-1895.
15. WHO. Hormonal contraception and HIV: technical statement. Geneva, Switzerland: World Health Organisation; 2012.
16. Population Reference Bureau. The World's Women and Girls 2011 Data Sheet; 2009.
17. Szwarcwald CL, Barbosa Júnior A, de Souza-Júnior PRB, de Lemos KRV, de Frias PG, Luhm KR, et al. HIV testing during pregnancy: use of secondary data to estimate 2006 test coverage and prevalence in Brazil. Braz J Infect Dis 2008; 12:167-172.
18. UNAIDS. AIDS info country factsheets; 2009.
19. Behets F, Edmonds A, Kitenge F, Crabbé F, Laga M. Heterogeneous and decreasing HIV prevalence among women seeking antenatal care in Kinshasa, Democratic Republic of Congo. Int J Epidemiol 2010; 39:1066-1073.
20. UNGASS Country Progress Report Thailand. National AIDS Prevention and Alleviation Committee; 2010.
21. United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2010 Revision (comprehensive Excel tables). New York; 2011.
22. Trussell J. Contraceptive efficacy. In: Hatcher R, Trussell J, Nelson A, Cates Jr. W, Kowal D, Policar M, editors. Contraceptive technology, 20th revised ed. New York: Ardent Media; 2011.
23. United Nations Department of Economic and Social Affairs, Population Division. World Fertility Data 2008 (POP/DB/Fert/Rev2008); 2009.
24. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010; 375:1609-1623.
25. WHO. Maternal Mortality Ratio (per 100 000 live births).
26. Population Reference Bureau. World Population Data Sheet; 2011.
27. WHO, UNAIDS, UNICEF. Global HIV/AIDS Response: Epidemic update and health sector response progress towards Universal Access, Progress Report 2011; 2011.
28. WHO, UNICEF, UNAIDS. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector; 2010.
29. Todd J, Glynn J, Marston M, Lutalo T, Biraro S, Mwita W, et al. Time fromHIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007; 21:S55-S63. (Pubitemid 350158889)
30. Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sex Transm Infect 2008; 84:i31-i36.
31. Mahy M, Lewden C, Brinkhof MWG, Dabis F, Tassie J-M, Souteyrand Y, et al. Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy. Sex Transm Infect 2010; 86:ii28-ii34.
32. Adler AJ, Filippi V, Thomas SL, Ronsmans C. Incidence of severe acute maternal morbidity associated with abortion: a systematic review. Trop Med Int Health 2012; 17:177-190.
33. Aring; hman E, Shah IH. New estimates and trends regarding unsafe abortion mortality. Int J Gynecol Obstet 2011; 115:121-126.
34. Singh S, Darroch J, Ashford L, Vlassoff M. Adding it up: the costs and benefits of investing in family planning and maternal and newborn health. New York: Guttmacher Institute and United Nations Population Fund; 2009.
35. Ross J, Hardee K, Mumford E, Eid S. Contraceptive method choice in developing countries. Int Fam Plan Perspect 2002; 28:32-40.
36. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. New Engl J Med 2011; 365:493-505.
37. Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, Bershteyn A, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 2012; 9:73-92.
38. Bärnighausen T, Becker S, Bendavid E, Bershteyn A, Blandford J, Boily M-C, et al. The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group. HIV treatment as prevention: models, data, and questions-towards evidence-based decision-making. PLoS Med 2012; 9:1-8.